ADMA Biologics Inc (ADMA) vs Celldex Therapeutics, Inc. (CLDX)
- ADMA Biologics Inc ADMA 10.68 −0.47%
- Celldex Therapeutics, Inc. CLDX 27.53 −4.84%
ADMA Biologics Inc and Celldex Therapeutics, Inc. are both Biotechnology companies. ADMA Biologics Inc and Celldex Therapeutics, Inc. are of similar size ($2.4B and $2.3B). Celldex Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; ADMA Biologics Inc trades at 14.8×. ADMA Biologics Inc grew revenue faster over the last twelve months: 8.04% against −88.3%. ADMA Biologics Inc has the higher net margin (33.0% vs −33,883.8%) and the higher return on invested capital (29.8% vs 0.00%). Across the 18 metrics below, ADMA Biologics Inc leads on 14 and Celldex Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ADMA | CLDX | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.71% | 100.00% | 65.16% |
| Operating margin | 43.82% | (36,733.82%) | 0.00% |
| Net margin | 32.98% | (33,883.77%) | 0.00% |
| Free cash flow margin | 22.69% | (27,294.81%) | 0.00% |
| Return on equity | 41.90% | (43.88%) | (56.36%) |
| Return on assets | 27.19% | (40.76%) | (48.04%) |
| Return on invested capital | 29.78% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack